| Literature DB >> 33297968 |
Yih-Jian Tsai1, Ping-Yen Yang1, Yi-Ching Yang2, Mau-Roung Lin3, Ying-Wei Wang4,5.
Abstract
BACKGROUND: An aging society incurs great losses due to fall-related injuries and mortalities. The foreseeable increased burden of fall-related injury among older people requires a regular nationwide study on the fall epidemic and prevention strategies.Entities:
Keywords: Elderly; Fall prevention; Prevalence; Risk factors
Mesh:
Year: 2020 PMID: 33297968 PMCID: PMC7724833 DOI: 10.1186/s12877-020-01922-z
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Characteristics of study subjects by number of participants and prevalence of falls during survey years
| Characteristics | 2005 | 2009 | 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of participants | Prevalence of falls and | No. of participants | Prevalence of falls and | No. of participants | Prevalence of falls and | |||||||
| % | n | % | % | n | % | % | n | % | ||||
| Total | 2722 | 100.0 | 579 | 21.3 | 2900 | 100.0 | 565 | 17.5 | 3200 | 100.0 | 528 | 16.5 |
| Mean age (±SD, year) | 75.1 | ±6.0 | 75.6 | ±6.3 | 76.4 | ±6.5 | ||||||
| Age | 0.002 | 0.017 | 0.004 | |||||||||
| 65–69 | 868 | 31.9 | 147 | 16.9 | 877 | 30.2 | 131 | 14.0 | 852 | 26.6 | 110 | 12.1 |
| 70–74 | 743 | 27.3 | 161 | 20.9 | 726 | 25.0 | 141 | 18.5 | 866 | 27.1 | 135 | 16.2 |
| 75–79 | 619 | 22.7 | 141 | 23.2 | 653 | 22.5 | 131 | 16.4 | 654 | 20.4 | 115 | 17.9 |
| 80–84 | 329 | 12.1 | 88 | 28.1 | 388 | 13.4 | 96 | 23.0 | 503 | 15.7 | 99 | 18.7 |
| 85+ | 163 | 6.0 | 42 | 26.1 | 256 | 8.8 | 66 | 21.3 | 325 | 10.2 | 69 | 24.3 |
| Sex | < 0.001 | < 0.001 | 0.224 | |||||||||
| Male | 1346 | 49.4 | 221 | 16.5 | 1252 | 43.2 | 198 | 14.1 | 1523 | 47.6 | 227 | 15.3 |
| Female | 1376 | 50.6 | 358 | 26.2 | 1648 | 56.8 | 367 | 20.6 | 1677 | 52.4 | 301 | 17.5 |
| ADL difficulty | < 0.001 | < 0.001 | < 0.001 | |||||||||
| None | 2324 | 85.4 | 419 | 18.1 | 2382 | 82.2 | 399 | 15.2 | 2658 | 83.1 | 379 | 13.8 |
| 1 task | 74 | 2.7 | 33 | 45.9 | 109 | 3.8 | 33 | 29.0 | 112 | 3.5 | 38 | 44.5 |
| ≥ 2 tasks | 322 | 11.8 | 127 | 39.4 | 406 | 14.0 | 133 | 28.4 | 427 | 13.4 | 111 | 27.2 |
| IADL difficulty | < 0.001 | < 0.001 | < 0.001 | |||||||||
| None | 1574 | 58.1 | 232 | 15.0 | 2275 | 79.4 | 371 | 14.8 | 1943 | 61.5 | 244 | 11.9 |
| 1 task | 361 | 13.3 | 67 | 19.0 | 105 | 3.7 | 28 | 25.1 | 349 | 11.0 | 57 | 16.0 |
| ≥ 2 tasks | 775 | 28.6 | 278 | 35.7 | 486 | 17.0 | 161 | 29.1 | 868 | 27.5 | 216 | 27.5 |
| Use of sleeping pills use | 0.005 | 0.022 | 0.009 | |||||||||
| No | 2422 | 89.1 | 496 | 20.4 | 2521 | 87.4 | 468 | 16.7 | 2715 | 85.1 | 422 | 15.4 |
| Yes | 297 | 10.9 | 83 | 28.6 | 363 | 12.6 | 94 | 22.9 | 477 | 14.9 | 106 | 22.3 |
| Vision | < 0.001 | 0.002 | < 0.001 | |||||||||
| Clear | 772 | 32.1 | 129 | 17.4 | 815 | 32.0 | 109 | 12.8 | 974 | 34.2 | 109 | 11.1 |
| Average | 1020 | 42.4 | 184 | 17.7 | 1097 | 43.1 | 206 | 17.0 | 1296 | 45.5 | 189 | 14.3 |
| Unclear | 615 | 25.6 | 166 | 28.1 | 635 | 24.9 | 159 | 22.2 | 579 | 20.3 | 146 | 27.7 |
| Frequency of exercise | 0.018 | 0.001 | < 0.001 | |||||||||
| None | 1246 | 45.8 | 298 | 24.2 | 1370 | 50.0 | 311 | 21.2 | 1524 | 50.4 | 301 | 20.3 |
| Irregular | 167 | 6.1 | 34 | 19.3 | 138 | 5.0 | 17 | 13.0 | 107 | 3.5 | 20 | 13.4 |
| Regular | 1306 | 48.0 | 247 | 19.1 | 1233 | 45.0 | 196 | 13.8 | 1394 | 46.1 | 170 | 12.6 |
| Comorbidities | < 0.001 | 0.051 | 0.022 | |||||||||
| 0 | 879 | 38.5 | 116 | 12.2 | 942 | 33.5 | 153 | 14.2 | 884 | 28.6 | 104 | 12.4 |
| 1 | 690 | 30.2 | 131 | 19.2 | 957 | 34.0 | 185 | 17.6 | 995 | 32.2 | 175 | 16.4 |
| ≥ 2 | 712 | 31.2 | 187 | 28.5 | 916 | 32.5 | 202 | 19.6 | 1207 | 39.1 | 218 | 18.5 |
| Urinary incontinence | < 0.001 | 0.002 | < 0.001 | |||||||||
| No | 2066 | 76.1 | 384 | 18.8 | 2603 | 90.2 | 485 | 16.5 | 2544 | 79.9 | 367 | 14.0 |
| Yes | 649 | 23.9 | 194 | 29.6 | 284 | 9.8 | 77 | 26.0 | 640 | 20.1 | 156 | 25.5 |
| Depressive symptoms | < 0.001 | < 0.001 | < 0.001 | |||||||||
| No | 1715 | 71.4 | 282 | 16.3 | 1999 | 76.4 | 297 | 13.6 | 2229 | 79.6 | 282 | 12.5 |
| Yes | 686 | 28.6 | 198 | 30.0 | 617 | 23.6 | 193 | 27.7 | 570 | 20.4 | 139 | 24.9 |
Note: p-value < 0.05 using the chi-square test indicates a statistically significant fall risk across each explanatory variable. The prevalence of falls was estimated by weighing according to sampling probability proportional to the population size. SD standard deviation
Distribution of falls across selected chronic conditions during the year of survey
| Characteristics | 2005 | 2009 | 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of participants | Prevalence of falls and | No. of participants | Prevalence of falls and | No. of participants | Prevalence of falls and | |||||||
| % | n | % | % | n | % | % | n | % | ||||
| Hypertension | < 0.001 | 0.002 | 0.078 | |||||||||
| No | 1514 | 56.9 | 277 | 17.4 | 1475 | 50.9 | 247 | 14.7 | 1482 | 46.5 | 221 | 14.7 |
| Yes | 1145 | 43.1 | 279 | 25.9 | 1421 | 49.1 | 317 | 20.3 | 1708 | 53.5 | 304 | 17.9 |
| Diabetes | < 0.001 | 0.032 | 0.131 | |||||||||
| No | 2181 | 82.2 | 424 | 19.7 | 2337 | 80.7 | 431 | 16.5 | 2471 | 77.5 | 386 | 15.7 |
| Yes | 473 | 17.8 | 134 | 28.4 | 560 | 19.3 | 134 | 21.5 | 717 | 22.5 | 137 | 18.9 |
| Hyperlipidemia | < 0.001 | 0.979 | 0.014 | |||||||||
| No | 1847 | 76.7 | 327 | 17.9 | 2159 | 76.0 | 421 | 17.2 | 2290 | 73.2 | 354 | 14.8 |
| Yes | 562 | 23.3 | 149 | 26.6 | 682 | 24.0 | 127 | 17.3 | 839 | 26.8 | 155 | 19.9 |
| Stroke | < 0.001 | 0.921 | < 0.001 | |||||||||
| No | 2493 | 92.4 | 504 | 20.1 | 2687 | 92.8 | 518 | 17.4 | 2918 | 91.3 | 448 | 15.0 |
| Yes | 206 | 7.6 | 67 | 35.5 | 210 | 7.2 | 45 | 17.7 | 277 | 8.7 | 79 | 32.4 |
| Transient ischemic attack | < 0.001 | 0.037 | 0.008 | |||||||||
| No | 2447 | 90.3 | 488 | 20.2 | 2702 | 93.7 | 514 | 16.9 | 2838 | 89.6 | 444 | 15.4 |
| Yes | 263 | 9.7 | 89 | 32.5 | 182 | 6.3 | 48 | 24.6 | 329 | 10.4 | 74 | 24.1 |
| Asthma | 0.050 | 0.001 | 0.648 | |||||||||
| No | 2561 | 94.9 | 533 | 20.9 | 2744 | 94.7 | 519 | 16.9 | 2993 | 93.7 | 496 | 16.6 |
| Yes | 140 | 5.2 | 38 | 29.1 | 155 | 5.3 | 46 | 29.6 | 201 | 6.3 | 30 | 15.0 |
| Kidney disease | < 0.001 | 0.464 | 0.006 | |||||||||
| No | 2375 | 91.1 | 467 | 19.5 | 2666 | 92.3 | 501 | 17.2 | 2884 | 90.4 | 456 | 15.5 |
| Yes | 232 | 8.9 | 72 | 33.9 | 223 | 7.7 | 60 | 19.7 | 308 | 9.6 | 70 | 24.3 |
Note: p < 0.05 using the chi-square test indicates a statistically significant fall risk across each explanatory variable. The prevalence of falls was estimated by weighing according to sampling probability proportional to the population size
Univariate logistic regression analyses for falls by the year of survey
| Covariate (reference) | 2005 | 2009 | 2013 |
|---|---|---|---|
| OR 95% CI | OR 95% CI | OR 95% CI | |
| Age (65–69) | |||
| 70–74 | 1.30 (0.99–1.71) | 1.40 (1.06–1.84) | 1.40 (1.04–1.89) |
| 75–79 | 1.48 (1.12–1.96) | 1.20 (0.90–1.62) | 1.58 (1.15–2.17) |
| 80–84 | 1.92 (1.39–2.65) | 1.83 (1.34–2.51) | 1.67 (1.20–2.34) |
| 85+ | 1.74 (1.14–2.65) | 1.66 (1.13–2.42) | 2.33 (1.62–3.35) |
| Sex (male) | |||
| Female | 1.80 (1.47–2.21) | 1.57 (1.28–1.93) | 1.18 (0.95–1.45) |
| ADL difficulty (none) | |||
| 1 task | 3.84 (2.34–6.30) | 2.29 (1.46–3.60) | 5.00 (3.22–7.75) |
| ≧2 tasks | 2.93 (2.23–3.85) | 2.22 (1.71–2.87) | 2.33 (1.77–3.07) |
| IADL difficulty (none) | |||
| 1 task | 1.32 (0.96–1.82) | 1.92 (1.18–3.11) | 1.42 (1.00–2.01) |
| ≧2 tasks | 3.14 (2.52–3.90) | 2.36 (1.85–3.00) | 2.82 (2.24–3.54) |
| Use of sleeping pills (no) | |||
| Yes | 1.56 (1.17–2.08) | 1.48 (1.11–1.96) | 1.58 (1.22–2.04) |
| Vision (clear) | |||
| Average | 1.02 (0.78–1.33) | 1.39 (1.07–1.82) | 1.33 (1.01–1.75) |
| Unclear | 1.86 (1.41–2.45) | 1.94 (1.44–2.60) | 3.07 (2.28–4.13) |
| Comorbidities (0) | |||
| 1 | 1.71 (1.27–2.30) | 1.30 (1.00–1.68) | 1.39 (1.03–1.86) |
| ≧2 | 2.86 (2.15–3.79) | 1.47 (1.14–1.91) | 1.60 (1.21–2.11) |
| Urinary incontinence (no) | |||
| Yes | 1.82 (1.46–2.26) | 1.78 (1.33–2.38) | 2.10 (1.67–2.65) |
| Depressive symptoms (no) | |||
| Yes | 2.20 (1.76–2.75) | 2.44 (1.94–3.07) | 2.32 (1.80–3.00) |
| Frequency of exercise (none) | |||
| Irregular | 0.75 (0.48–1.17) | 0.56 (0.34–0.91) | 0.60 (0.33–1.10) |
| Regular | 0.74 (0.60–0.91) | 0.60 (0.48–0.74) | 0.57 (0.45–0.71) |
Fig. 1Time trends in the prevalence of falls and fall-related hospitalization rates
Multivariate logistic regression analyses for falls by the year of survey
| Covariate (reference) | 2005 | 2009 | 2013 | |||
|---|---|---|---|---|---|---|
| Age (65–69) | ||||||
| 70–74 | 1.16 | (0.83–1.62) | 1.26 | (0.93–1.69) | 1.13 | (0.81–1.58) |
| 75–79 | 1.24 | (0.87–1.76) | 0.87 | (0.62–1.22) | 1.17 | (0.81–1.70) |
| 80+ | 1.34 | (0.88–2.03) | 1.35 | (0.97–1.89) | 1.19 | (0.82–1.73) |
| Sex (male) | ||||||
| Female | 1.64 | (1.26–2.15) | 1.38 | (1.09–1.76) | 0.93 | (0.72–1.20) |
| ADL difficulty (none) | ||||||
| 1 task | 2.39 | (1.25–4.58) | 0.44 | (0.10–1.87) | 2.74 | (1.55–4.86) |
| ≥ 2 tasks | 1.41 | (0.80–2.47) | 0.42 | (0.09–2.04) | 1.14 | (0.66–1.95) |
| IADL difficulty (none) | ||||||
| 1 task | 0.76 | (0.51–1.14) | 1.41 | (0.74–2.72) | 1.13 | (0.77–1.66) |
| ≥ 2 tasks | 1.45 | (1.00–2.11) | 4.56 | (0.98–21.23) | 1.27 | (0.85–1.90) |
| Use of sleeping pills (no) | ||||||
| Yes | 1.09 | (0.75–1.60) | 1.06 | (0.75–1.49) | 1.21 | (0.88–1.67) |
| Vision (clear) | ||||||
| Average | 0.93 | (0.69–1.27) | 1.25 | (0.94–1.65) | 1.10 | (0.82–1.48) |
| Unclear | 1.09 | (0.77–1.55) | 1.23 | (0.88–1.71) | 1.92 | (1.36–2.72) |
| Comorbidities (0) | ||||||
| 1 | 1.61 | (1.16–2.24) | 1.16 | (0.87–1.54) | 1.18 | (0.85–1.64) |
| ≥ 2 | 2.41 | (1.74–3.35) | 1.19 | (0.89–1.61) | 1.12 | (0.81–1.54) |
| Urinary incontinence (no) | ||||||
| Yes | 1.09 | (0.80–1.49) | 1.29 | (0.90–1.84) | 1.42 | (1.04–1.94) |
| Depressive symptoms (no) | ||||||
| Yes | 1.51 | (1.12–2.03) | 1.77 | (1.35–2.31) | 1.45 | (1.06–1.98) |
| Frequency of exercise (none) | ||||||
| Irregular | 1.20 | (0.70–2.04) | 0.77 | (0.46–1.29) | 0.87 | (0.45–1.69) |
| Regular | 1.12 | (0.85–1.49) | 0.81 | (0.63–1.04) | 0.80 | (0.62–1.03) |
Note: Adjusted odds ratios and 95% confidence interval (OR and 95%CI) are presented for each dummy variable. Variables controlled across three waves of survey in the MLR model included age, sex, developing difficulty in performing ADLs or IADLs, use of sleeping pills, vision, comorbidities, urinary incontinence, depressive symptoms, and frequency of exercise
Fig. 2Effect sizes of prevalence of falls and fall-related hospitalization rates during 2005 and 2009